Interleukin-22 Deficiency Accelerates the Rejection of Full Major Histocompatibility Complex-Disparate Heart Allografts

Transplantation Proceedings

Volumn 40, Issue 5, 2008, Pages 1593-1597

  Kapessidou, P ^a   Poulin, L ^a   Dumoutier, L ^b   Goldman, M ^a   Renauld, J C ^b   Braun, M Y ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b DE DUVE INSTITUTE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; GLYCOPROTEIN; INTERLEUKIN 17; INTERLEUKIN 22; INTERLEUKIN 23; LYMPHOKINE; PROTEIN MAC3;

ACUTE GRAFT REJECTION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; C57BL 6 MOUSE; CD4+ T LYMPHOCYTE; CYTOKINE PRODUCTION; GRAFT NECROSIS; GRAFT REJECTION; GRANULOCYTE; HEART TRANSPLANTATION; HISTOPATHOLOGY; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; THROMBOSIS;

ANIMALS; EXONS; GRAFT REJECTION; HEART TRANSPLANTATION; INTERLEUKINS; MAJOR HISTOCOMPATIBILITY COMPLEX; MICE; MICE, INBRED BALB C; MODELS, ANIMAL; TRANSCRIPTION, GENETIC; TRANSPLANTATION, HOMOLOGOUS;

EID: 45749137569     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.03.151     Document Type: Article

References (26)

1. Sabat R., Wallace E., Endesfelder S., et al. IL-19 and IL-20: two novel cytokines with importance in inflammatory diseases. Expert Opin Ther Targets 11 (2007) 601
2. Donnelly R.P., Sheikh F., Kotenko S.V., et al. The expanded family of class II cytokines that share the IL-10 receptor-2 (IL-10R2) chain. J Leukoc Biol 76 (2004) 314
3. Dumoutier L., Louahed J., and Renauld J.C. Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9. J Immunol 164 (2000) 1814
4. Dumoutier L., Van R.E., Colau D., et al. Human interleukin-10-related T cell-derived inducible factor: molecular cloning and functional characterization as an hepatocyte-stimulating factor. Proc Natl Acad Sci USA 97 (2000) 10144
5. Wolk K., Kunz S., Asadullah K., et al. Cutting edge: immune cells as sources and targets of the IL-10 family members?. J Immunol 168 (2002) 5397
6. Wolk K., Kunz S., Witte E., et al. IL-22 increases the innate immunity of tissues. Immunity 21 (2004) 241
7. Liang S.C., Tan X.Y., Luxenberg D.P., et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 203 (2006) 2271
8. Zheng Y., Danilenko D.M., Valdez P., et al. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445 (2007) 648
9. Ramesh R., Mhashilkar A.M., Tanaka F., et al. Melanoma differentiation-associated gene 7/interleukin (IL)-24 is a novel ligand that regulates angiogenesis via the IL-22 receptor. Cancer Res 63 (2003) 5105
10. Antonysamy M.A., Fanslow W.C., Fu F., et al. Evidence for a role of IL-17 in organ allograft rejection: IL-17 promotes the functional differentiation of dendritic cell progenitors. J Immunol 162 (1999) 577
11. Tang J.L., Subbotin V.M., Antonysamy M.A., et al. Interleukin-17 antagonism inhibits acute but not chronic vascular rejection. Transplantation 72 (2001) 348
12. Loong C.C., Hsieh H.G., Lui W.Y., et al. Evidence for the early involvement of interleukin 17 in human and experimental renal allograft rejection. J Pathol 197 (2002) 322
13. Vanaudenaerde B.M., Dupont L.J., Wuyts W.A., et al. The role of interleukin-17 during acute rejection after lung transplantation. Eur Respir J 27 (2006) 779
14. Verleden G.M., Vos R., Vanaudenaerde B.M., et al. Interleukin-17 and neutrophils are increased in BAL fluid during acute lung rejection. Chest 131 (2007) 1988
15. Poulin L.F., Richard M., Le Moine A., et al. Interleukin-9 promotes eosinophilic rejection of mouse heart allografts. Transplantation 76 (2003) 572
16. Buonocore S., Flamand V., Goldman M., et al. Bone marrow-derived immature dendritic cells prime in vivo alloreactive T cells for interleukin-4-dependent rejection of major histocompatibility complex class II antigen-disparate cardiac allograft. Transplantation 75 (2003) 407
17. + T cells. Transplantation 82 (2006) 582
18. Chang H., Hanawa H., Liu H., et al. Hydrodynamic-based delivery of an interleukin-22-Ig fusion gene ameliorates experimental autoimmune myocarditis in rats. J Immunol 177 (2006) 3635
19. Radaeva S., Sun R., Pan H.N., et al. Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation. Hepatology 39 (2004) 1332
20. Pan H., Hong F., Radaeva S., et al. Hydrodynamic gene delivery of interleukin-22 protects the mouse liver from concanavalin A-, carbon tetrachloride-, and Fas ligand-induced injury via activation of STAT3. Cell Mol Immunol 1 (2004) 43
21. Liang S.C., Tan X.Y., Luxenberg D.P., et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 203 (2006) 2271
22. Al-Roof Higazi A., Ganz T., Kariko K., et al. Defensin modulates tissue-type plasminogen activator and plasminogen binding to fibrin and endothelial cells. J Biol Chem 271 (1996) 17650
23. Kougias P., Chai H., Lin P.H., et al. Defensins and cathelicidins: neutrophil peptides with roles in inflammation, hyperlipidemia and atherosclerosis. J Cell Mol Med 9 (2005) 3
24. Austyn J.M., Hankins D.F., Larsen C.P., et al. Isolation and characterization of dendritic cells from mouse heart and kidney. J Immunol 152 (1994) 2401
25. Whittington H.A., Armstrong L., Uppington K.M., et al. Interleukin-22: a potential immunomodulatory molecule in the lung. Am J Respir Cell Mol Biol 31 (2004) 220
26. Hsing C.H., Hsieh M.Y., Chen W.Y., et al. Induction of interleukin-19 and interleukin-22 after cardiac surgery with cardiopulmonary bypass. Ann Thorac Surg 81 (2006) 2196